Our first step was to examine the IHC expression of the two gluconeogenic enzymes (PCK1 and PCK2), and of the glucose transporter mediating glycolysis (GLUT1) in primary NSCLC samples, comparing expression profiles in LUAD versus LUSC. This evidence concerns the gene PCK1 and non-small cell lung carcinoma.